Arbutus Biopharma Corporation · NASDAQ:ABUS

Morgan Stanley reported a 13.50% stake in Arbutus Biopharma Corporation (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 11, 2026

Morgan Stanley reported a 13.50% stake in Arbutus Biopharma Corporation, 25,910,337 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G/A).

Stake
13.50%
Shares
25,910,337
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Morgan Stanley13.50%25,910,337
Morgan Stanley Investment Management Inc.13.30%25,647,127

Source

View original at SEC

Related